BioScrip, Inc. (NASDAQ:BIOS)

CAPS Rating: 2 out of 5

The Company provides pharmaceutical and pharmacy benefit management services.

Recs

0
Player Avatar 21popsontop (< 20) Submitted: 12/1/2010 1:43:18 PM : Outperform Start Price: $4.48 BIOS Score: +41.14

Longshots under $5 screen.

Report this Post Reply

Featured Broker Partners


Advertisement